Analysts at StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Get Free Report) in a note issued to investors on Monday. The firm set a “hold” rating on the specialty pharmaceutical company’s stock.
Cumberland Pharmaceuticals Price Performance
Shares of Cumberland Pharmaceuticals stock opened at $1.22 on Monday. The company has a market capitalization of $17.31 million, a price-to-earnings ratio of -2.07 and a beta of 0.20. The company has a quick ratio of 1.26, a current ratio of 1.44 and a debt-to-equity ratio of 0.62. The stock’s 50-day simple moving average is $1.38 and its 200-day simple moving average is $1.52. Cumberland Pharmaceuticals has a 52 week low of $1.22 and a 52 week high of $2.36.
Cumberland Pharmaceuticals Company Profile
Recommended Stories
- Five stocks we like better than Cumberland Pharmaceuticals
- What is the Nikkei 225 index?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Conference Calls and Individual Investors
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.